IPSC
Price
$2.20
Change
-$0.05 (-2.22%)
Updated
Jul 13 closing price
Capitalization
396.78M
23 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$20.41
Change
+$0.05 (+0.25%)
Updated
Jul 13 closing price
Capitalization
1.71B
29 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IPSC vs MLTX

IPSC vs MLTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IPSC vs. MLTX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Buy and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (IPSC: $2.20 vs. MLTX: $20.41)
Brand notoriety: IPSC and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 61% vs. MLTX: 70%
Market capitalization -- IPSC: $396.78M vs. MLTX: $1.71B
IPSC [@Biotechnology] is valued at $396.78M. MLTX’s [@Biotechnology] market capitalization is $1.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 5 TA indicator(s) are bullish while MLTX’s TA Score has 6 bullish TA indicator(s).

  • IPSC’s TA Score: 5 bullish, 4 bearish.
  • MLTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than IPSC.

Price Growth

IPSC (@Biotechnology) experienced а -8.33% price change this week, while MLTX (@Biotechnology) price change was +8.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

IPSC is expected to report earnings on Aug 06, 2026.

MLTX is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($1.71B) has a higher market cap than IPSC($397M). IPSC YTD gains are higher at: 121.150 vs. MLTX (54.856). IPSC has higher annual earnings (EBITDA): -95.48M vs. MLTX (-245.81M). MLTX has more cash in the bank: 358M vs. IPSC (135M). IPSC has less debt than MLTX: IPSC (48M) vs MLTX (101M). IPSC (0) and MLTX (0) have equivalent revenues.
IPSCMLTXIPSC / MLTX
Capitalization397M1.71B23%
EBITDA-95.48M-245.81M39%
Gain YTD121.15054.856221%
P/E RatioN/AN/A-
Revenue00-
Total Cash135M358M38%
Total Debt48M101M48%
TECHNICAL ANALYSIS
Technical Analysis
IPSCMLTX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
64%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 18 days ago
85%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 12 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSCZX19.81N/A
N/A
GuideStone Funds Small Cap Equity Inv
HDGVX39.60N/A
N/A
Hartford Dividend and Growth R6
MSOPX30.05N/A
N/A
Morgan Stanley Inst Global Opp C
PWDCX12.08N/A
N/A
DF Tactical Dividend Fund C
VVIMX13.88N/A
N/A
Voya VACS Index MC